327ϊ(ΰ)@15:00`17:30@Jοκ _Λw@εw@BΩ@2F@B203 IS02 Potential disease-modifying therapeutics for neurodegenerative disorders Potential Disease-Modifying Therapeutics for Neurodegenerative Disorders I[KiCU[Fi _iA MATSUMOTO Rae R. IS02-1 Effect of Added Alkalizer and Surfactant on Dissolution and Absorption of a Novel CGRP Inhibitor Effect of Added Alkalizer and Surfactant on Dissolution and Absorption of a Novel CGRP Inhibitor V|WXg F TEMPLETON Allen CA ZHANG DinaA KRESS Michael H IS02-2 Role of Sigma-1 Receptors in Neurodegenerative Diseases Role of Sigma-1 Receptors in Neurodegenerative Diseases V|WXg F MATSUMOTO Rae R. IS02-3 Disease-Modifying Therapy through Enhancement of Neprilysin Activity for Alzheimer's Disease Disease-Modifying Therapy through Enhancement of Neprilysin Activity for Alzheimer's Disease V|WXg F βc Ci IS02-4 Disease-Modifying Therapeutics for Parkinson's Disease and Amyotrophic Lateral Sclerosis Disease-Modifying Therapeutics for Parkinson's Disease and Amyotrophic Lateral Sclerosis V|WXg F i _i υy[WΙίι
